A high‐throughput RNAi screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

Abstract The success of T cell‐based cancer immunotherapy is limited by tumor's resistance against killing by cytotoxic T lymphocytes (CTLs). Tumor‐immune resistance is mediated by cell surface ligands that engage immune‐inhibitory receptors on T cells. These ligands represent potent targets for the...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Nisit Khandelwal, Marco Breinig, Tobias Speck, Tillmann Michels, Christiane Kreutzer, Antonio Sorrentino, Ashwini Kumar Sharma, Ludmila Umansky, Heinke Conrad, Isabel Poschke, Rienk Offringa, Rainer König, Helga Bernhard, Arthur Machlenkin, Michael Boutros, Philipp Beckhove
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Springer Nature 2015-02-01
Reeks:	EMBO Molecular Medicine
Onderwerpen:	cancer immunotherapy immune suppression RNAi screen
Online toegang:	https://doi.org/10.15252/emmm.201404414
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!